The development of the comprehensive regenerative care clinic for people with diabetes is supported by the Center of Regenerative Medicine at Mayo Clinic. A Behfar has the following disclosures: Rion LLC, Co-Founder and Board of Directors Sorento Therapeutics, Stock holder Deverra Therapeutics, Share holder Chenoa Donoghue discloses: Stockholder for Metronic, Pfizer and Merck. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.